taxifolin has been researched along with Acute Confusional Senile Dementia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 5 (62.50) | 2.80 |
| Authors | Studies |
|---|---|
| Carver, JA; Duggan, PJ; Ecroyd, H; Liu, Y; Meyer, AG; Tranberg, CE | 1 |
| Akagi, K; Irie, K; Katayama, S; Masuda, Y; Murakami, K; Nakagawa, Y; Sato, M; Takegoshi, K; Uno, M | 1 |
| Kumar, S; Mishra, S; Modi, G; Rai, H; Singh, G; Singh, GK; Singh, YP; Srikrishna, S | 1 |
| Yang, R; Yang, X; Zhang, F | 1 |
| Hattori, M; Hattori, Y; Ihara, M; Nakaoku, Y; Nakatsuji, M; Nishimura, K; Ogata, S; Saito, S | 1 |
| Katasonov, AB | 1 |
| Ihara, M; Inoue, T; Saito, S; Satoh-Asahara, N; Tanaka, M | 2 |
4 review(s) available for taxifolin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Cell Line, Tumor; Coumaric Acids; Humans; Neuroprotective Agents; Oxidative Stress; Protein Multimerization | 2021 |
New Perspectives of Taxifolin in Neurodegenerative Diseases.
Topics: Alzheimer Disease; Cerebral Amyloid Angiopathy; Humans; Neurodegenerative Diseases; Quercetin | 2023 |
Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Biomarkers; Brain; Cerebral Amyloid Angiopathy; Cilostazol; Disease Models, Animal; Humans; Membrane Glycoproteins; Mice; Neuroprotective Agents; Oxidative Stress; Protein Aggregation, Pathological; Quercetin; Receptors, Immunologic | 2020 |
Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cerebral Amyloid Angiopathy; Humans; Neuroprotective Agents; Quercetin | 2019 |
4 other study(ies) available for taxifolin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Caseins; Flavonoids; Humans; Methylation; Milk; Structure-Activity Relationship | 2010 |
Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Catechols; Humans; Lysine; Norleucine; Peptide Fragments; Quercetin | 2013 |
Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cognition; Cognitive Dysfunction; Dementia; Humans; Neuropsychological Tests; Prospective Studies; Retrospective Studies | 2023 |
[Dihydroquercetin as a systemic neuroprotector for the prevention and treatment of β-amyloid-associated brain diseases].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Cerebral Amyloid Angiopathy; Humans | 2023 |